Temitope Oluwafemi Rude, MD
Urology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rude’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A156737 · Current
Licensed to practise in California · since 2018 · expires 2028-07-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$155,312
Medicare paid this office $155,312 for 547 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 175 | $25,472 | $113 |
| New patient visit (45+ min) | 143 | $18,317 | $128 |
| New patient visit (45+ min) | 103 | $10,919 | $106 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 12 | $8,678 | $723 |
| Return visit (30+ min) | 92 | $8,222 | $80 |
See all 20 services
| Return visit (30+ min) | 175 | $25,472 | $113 |
| New patient visit (45+ min) | 143 | $18,317 | $128 |
| New patient visit (45+ min) | 103 | $10,919 | $106 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 12 | $8,678 | $723 |
| Return visit (30+ min) | 92 | $8,222 | $80 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 51 | $5,539 | $109 |
| Insertion of sacral nerve neurostimulator electrode array | 15 | $5,185 | $324 |
| Diagnostic exam of bladder and urethra using an endoscope | 22 | $3,835 | $174 |
| Diagnostic exam of bladder and urethra using an endoscope | 51 | $3,565 | $69 |
| Long return visit (40+ min) | 18 | $2,706 | $150 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $2,167 | $181 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 14 | $2,150 | $143 |
| Insertion of device into abdomen with pressure and urine flow rate study | 51 | $1,767 | $35 |
| Long return visit (40+ min) | 11 | $1,434 | $119 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $1,078 | $90 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 50 | $809 | $16 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 40 | $563 | $14 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $254 | $21 |
| Electronic assessment of bladder emptying | 44 | $202 | $4 |
| Electronic assessment of bladder emptying | 16 | $76 | $4 |
Procedures Medicare counted
| Prostate resection | 20 | More than 80% of doctors who do this |
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
547 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 7% · Women 55% · Also on Medicaid 27% · Health risk score 1.55. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 71% · Diabetes 29% · Chronic kidney disease 29% · Coronary heart disease 27% · Cancer 25% · Depression 23% · Atrial fibrillation 18% · Heart failure 16% · COPD 13% · Dementia 9% · Stroke 9%.
The office billed $1,689,322, Medicare allowed $201,175 and paid $155,312; for 1,899 services of 72 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 547 | 1,899 | 74 | 1.55 | $1,689,322 | $155,312 |
| 2023 | 200 | 2,669 | 72 | 1.19 | $510,167 | $59,844 |
| 2022 | 279 | 4,062 | 71 | 1.20 | $1,268,760 | $118,860 |
| 2021 | 245 | 5,190 | 72 | 1.15 | $1,047,044 | $106,546 |
| 2020 | 66 | 757 | 70 | 1.24 | $202,022 | $20,628 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Botox | 13 | $9,930 | None |
| Return visit (30+ min) | 52 | $5,824 | $102 |
| New patient visit (45+ min) | 34 | $4,482 | $132 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 11 | $3,091 | $281 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 11 | $2,954 | $269 |
| New patient visit (45+ min) | 22 | $2,700 | $123 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $2,395 | $171 |
| Long return visit (40+ min) | 11 | $1,768 | $161 |
| Return visit (30+ min) | 17 | $1,716 | $90 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,634 | $149 |
| Short return visit (20+ min) | 17 | $1,155 | $68 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $269 | $24 |
| Ultrasound measurement of bladder capacity after voiding | 25 | $226 | $8 |
| Manual urinalysis test with examination using microscope, automated | 31 | $143 | $3 |
| Urinalysis, manual test | 12 | $41 | $3 |
2022: 22 services
| Return visit (30+ min) | 108 | $13,838 | $92 |
| Insertion of lower leg neurostimulator electrode | 16 | $10,580 | $93 |
| Diagnostic exam of bladder and urethra using an endoscope | 38 | $9,288 | $166 |
| Botox | 13 | $7,837 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 20 | $5,395 | $270 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 13 | $4,899 | $306 |
| New patient visit (60+ min) | 25 | $3,734 | $149 |
| New patient visit (45+ min) | 33 | $3,430 | $104 |
| Insertion of device into abdomen with pressure and urine flow rate study | 20 | $3,086 | $154 |
| Short return visit (20+ min) | 40 | $2,723 | $61 |
| Insertion of stent in ureter using an endoscope | 12 | $1,338 | $112 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 11 | $1,031 | $94 |
| Simple insertion of temporary bladder tube | 13 | $859 | $48 |
| Ultrasound measurement of bladder capacity after voiding | 97 | $830 | $7 |
| Simple bladder irrigation and/or instillation | 12 | $767 | $51 |
| Manual urinalysis test with examination using microscope, automated | 86 | $400 | $3 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 16 | $393 | $25 |
| Urinalysis, manual test | 29 | $145 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 21 | $134 | $6 |
| Insertion of needle into vein for collection of blood sample | 39 | $133 | $3 |
| Automated urinalysis test | 31 | $129 | $2 |
| Electronic assessment of bladder emptying | 16 | $115 | $7 |
2021: 14 services
| Botox | 19 | $10,288 | None |
| Return visit (30+ min) | 67 | $7,714 | $91 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 14 | $4,844 | $323 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $4,799 | $178 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $4,379 | $274 |
| Short return visit (20+ min) | 53 | $3,875 | $68 |
| New patient visit (60+ min) | 23 | $3,473 | $151 |
| New patient visit (45+ min) | 33 | $3,372 | $102 |
| Ultrasound measurement of bladder capacity after voiding | 72 | $730 | $7 |
| Manual urinalysis test with examination using microscope, automated | 87 | $422 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 26 | $188 | $6 |
| Automated urinalysis test | 27 | $140 | $2 |
| Insertion of needle into vein for collection of blood sample | 36 | $120 | $3 |
| Urinalysis, manual test | 15 | $56 | $3 |
2020: 5 services
| New patient visit (45+ min) | 12 | $1,518 | $126 |
| Return visit (30+ min) | 11 | $925 | $84 |
| Short return visit (20+ min) | 13 | $809 | $58 |
| Ultrasound measurement of bladder capacity after voiding | 19 | $163 | $8 |
| Manual urinalysis test with examination using microscope, automated | 22 | $95 | $3 |
Medicaid work
$14,038 in 2024
Medicaid paid $14,038 for 232 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 110 | $9,845 |
| Return visit (30+ min) | 72 | $3,936 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 38 | $236 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 12 | $21 |
| 2024 | 232 | 4 | 17 | $14,038 |
Drugs they prescribed that Part D paid
$174,808
Pharmacies billed $174,808 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
438 generic and fewer than 11 brand-name prescriptions · $174,808 in drug cost · 58 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 133 | $95,423 | $717 |
| Myrbetriq | 95 | $54,711 | $576 |
| Estradiol | 128 | $7,080 | $55 |
| Methenamine Hippurate | 65 | $3,814 | $59 |
| Trospium Chloride Er | 17 | $2,367 | $139 |
See all 10 drugs
| Gemtesa | 133 | $95,423 | $717 |
| Myrbetriq | 95 | $54,711 | $576 |
| Estradiol | 128 | $7,080 | $55 |
| Methenamine Hippurate | 65 | $3,814 | $59 |
| Trospium Chloride Er | 17 | $2,367 | $139 |
| Trospium Chloride | 30 | $1,306 | $44 |
| Tamsulosin | 54 | $1,005 | $19 |
| Cefpodoxime Proxetil | 14 | $378 | $27 |
| Finasteride | 16 | $245 | $15 |
| Nitrofurantoin Mono-Macro | 19 | $227 | $12 |
Year by year
| 2024 | 688 | 274 | None | None | $174,808 |
| 2023 | 337 | 122 | 0% (0) | 40% | $103,789 |
| 2022 | 732 | 201 | 0% (0) | None | $144,258 |
| 2021 | 478 | 157 | None | 25% | $73,828 |
| 2020 | 57 | 31 | 0% (0) | 21% | $6,990 |
| 2019 | 187 | 67 | None | 49% | $41,121 |
| 2018 | 106 | 61 | 16% (17) | 23% | $11,788 |
| 2017 | 35 | 26 | 0% (0) | None | $537 |
| 2016 | 91 | 43 | None | None | $3,914 |
| 2015 | 141 | 72 | 9% (12) | None | $3,207 |
| 2014 | 82 | 24 | None | None | $3,076 |
| 2013 | 30 | 13 | None | None | $1,419 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Myrbetriq | 110 | $85,438 | $777 |
| Methenamine Hippurate | 24 | $2,964 | $123 |
| Estradiol | 16 | $1,137 | $71 |
| Trospium Chloride | 14 | $741 | $53 |
| Tamsulosin | 22 | $476 | $22 |
| Finasteride | 22 | $409 | $19 |
2022: 17 drugs
| Myrbetriq | 198 | $116,918 | $590 |
| Gemtesa | 18 | $9,299 | $517 |
| Methenamine Hippurate | 73 | $5,640 | $77 |
| Estradiol | 23 | $3,041 | $132 |
| Trospium Chloride | 27 | $1,479 | $55 |
| Tamsulosin | 51 | $965 | $19 |
| Solifenacin | 19 | $858 | $45 |
| Finasteride | 45 | $852 | $19 |
| Nitrofurantoin Mono-Macro | 45 | $756 | $17 |
| Gentamicin Sulfate | 15 | $626 | $42 |
| Oxybutynin Chloride Er | 11 | $425 | $39 |
| Sodium Chloride | 14 | $192 | $14 |
| Nystop | 12 | $168 | $14 |
| Ciprofloxacin | 36 | $152 | $4 |
| Sulfamethoxazole-Trimethoprim | 34 | $109 | $3 |
| Fluconazole | 15 | $83 | $6 |
| Triamcinolone Acetonide | 11 | $42 | $4 |
2021: 11 drugs
| Myrbetriq | 91 | $56,790 | $624 |
| Methenamine Hippurate | 59 | $4,535 | $77 |
| Estradiol | 18 | $3,182 | $177 |
| Trospium Chloride Er | 14 | $1,797 | $128 |
| Nitrofurantoin Mono-Macro | 35 | $1,125 | $32 |
| Cefpodoxime Proxetil | 14 | $798 | $57 |
| Tamsulosin | 38 | $735 | $19 |
| Finasteride | 28 | $570 | $20 |
| Nystop | 13 | $226 | $17 |
| Sulfamethoxazole-Trimethoprim | 27 | $104 | $4 |
| Ciprofloxacin | 15 | $56 | $4 |
2019: 3 drugs
| Myrbetriq | 55 | $21,334 | $388 |
| Toviaz | 12 | $4,586 | $382 |
| Methenamine Hippurate | 32 | $2,045 | $64 |
2018: 2 drugs
| Myrbetriq | 12 | $4,857 | $405 |
| Tramadol | 12 | $47 | $4 |
2016: 3 drugs
| Oxybutynin Chloride Er | 17 | $574 | $34 |
| Tamsulosin | 16 | $411 | $26 |
| Finasteride | 11 | $188 | $17 |
2015: 3 drugs
| Oxybutynin Chloride Er | 17 | $714 | $42 |
| Finasteride | 26 | $375 | $14 |
| Ciprofloxacin | 18 | $69 | $4 |
2014: 2 drugs
| Tamsulosin | 37 | $645 | $17 |
| Finasteride | 12 | $190 | $16 |
Money from drug and device companies
$5,752 in 2025
| 2025 | 5 | 31 | None | $5,752 |
| 2024 | 7 | 36 | None | $3,183 |
| 2023 | 2 | 7 | None | $696 |
| 2022 | 2 | 2 | None | $154 |
| 2021 | 1 | 1 | None | $103 |
| 2020 | 2 | 4 | None | $352 |
| 2019 | 3 | 8 | None | $791 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $3,547 | 10 payments
|
| Medtronic | Altaviva | $1,695 | 15 payments
|
| Valencia Technologies | Ecoin Device Kit | $186 | 2 payments
|
| Bluewind Medical | Revi | $166 | 2 payments
|
| Boston Scientific | Moses | $157 | 2 payments
|
See all 31 published payments
| Intuitive Surgical | Meals · 2025-12-30 | Da Vinci Surgical System | $119 |
| Intuitive Surgical | Meals · 2025-12-23 | Da Vinci Surgical System | $113 |
| Intuitive Surgical | Meals · 2025-12-22 | Da Vinci Surgical System | $16 |
| Intuitive Surgical | Education · 2025-12-22 | Da Vinci Sp | $1,500 |
| Intuitive Surgical | Travel · 2025-12-05 | Da Vinci Surgical System | $242 |
| Intuitive Surgical | Travel · 2025-12-02 | Da Vinci Surgical System | $448 |
| Medtronic | Meals · 2025-11-14 | Interstim | $113 |
| Intuitive Surgical | Travel · 2025-11-12 | Da Vinci Surgical System | $30 |
| Intuitive Surgical | Travel · 2025-11-12 | Da Vinci Surgical System | $467 |
| Medtronic | Meals · 2025-11-09 | Altaviva | $12 |
| Medtronic | Meals · 2025-11-09 | Altaviva | $156 |
| Medtronic | Travel · 2025-11-08 | Altaviva | $21 |
| Medtronic | Travel · 2025-11-08 | Altaviva | $57 |
| Medtronic | Travel · 2025-11-08 | Altaviva | $169 |
| Medtronic | Travel · 2025-11-08 | Altaviva | $19 |
| Medtronic | Meals · 2025-11-07 | Altaviva | $28 |
| Medtronic | Meals · 2025-11-07 | Altaviva | $40 |
| Medtronic | Travel · 2025-11-04 | Altaviva | $616 |
| Medtronic | Travel · 2025-11-04 | Altaviva | $35 |
| Intuitive Surgical | Travel · 2025-11-03 | Da Vinci Surgical System | $30 |
| Intuitive Surgical | Travel · 2025-11-03 | Da Vinci Surgical System | $583 |
| Medtronic | Meals · 2025-10-30 | Interstim | $167 |
| Bluewind Medical | Meals · 2025-10-24 | Revi | $19 |
| Medtronic | Meals · 2025-10-17 | Altaviva | $78 |
| Valencia Technologies | Meals · 2025-09-05 | Ecoin Device Kit | $118 |
| Medtronic | Meals · 2025-07-25 | Interstim | $127 |
| Boston Scientific | Meals · 2025-07-14 | Moses | $137 |
| Medtronic | Meals · 2025-06-27 | Interstim | $57 |
| Boston Scientific | Meals · 2025-06-03 | Bulkamid | $20 |
| Bluewind Medical | Meals · 2025-04-29 | Revi | $147 |
| Valencia Technologies | Meals · 2025-04-26 | Ecoin Device Kit | $68 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,183
| Medtronic | Interstim | $1,567 | 18 payments
|
| Boston Scientific | Moses 550 Dfl | $1,096 | 10 payments
|
| Valencia Technologies | Ecoin Device Kit | $267 | 4 payments
|
| Ethicon US | Echelon Flex | $126 | 1 payment
|
| Bluewind Medical | Revi | $96 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $20 | 1 payment
|
| Laborie Medical Technologies | Optilume Bph Drug Coated Balloon Catheter | $11 | 1 payment
|
2023: $696
| Medtronic | Interstim | $410 | 5 payments
|
| Valencia Technologies | Ecoin Device Kit | $286 | 2 payments
|
2022: $154
| Boston Scientific | Advantage System | $85 | 1 payment
|
| Medtronic | Interstim | $69 | 1 payment
|
2021: $103
| Boston Scientific | Upsylon | $103 | 1 payment
|
2020: $352
| Boston Scientific | Ams | $287 | 3 payments
|
| Medtronic USA | Interstim | $66 | 1 payment
|
2019: $791
| Medtronic USA | Interstim | $564 | 6 payments
|
| Allergan | Botox Cosmetic | $136 | 1 payment
|
| Boston Scientific | Ams | $92 | 1 payment
|
Professional record
- NPI
- 1245678051
- Licence
- CA A156737California A156737: Current · expires 2028-07-31
- Trained
- Stanford University School of Medicine, 2013
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WI 1245678051
- Taxonomy
- Urology (208800000X); Federal specialty code 2088F0040X (2088F0040X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-06-13
- NPI last updated
- 2024-03-13
- NPI record certified
- 2024-03-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1313 Fish Hatchery Rd, Madison, WI, 53715
This office lists an electronic records connection.